Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
UBS
Deloitte
Farmers Insurance
Colorcon
Fuji
US Army
Moodys
McKesson

Generated: December 15, 2018

DrugPatentWatch Database Preview

Alvogen Malta Company Profile

« Back to Dashboard

What is the competitive landscape for ALVOGEN MALTA, and what generic and branded alternatives to ALVOGEN MALTA drugs are available?

ALVOGEN MALTA has twenty-four approved drugs.



Summary for Alvogen Malta
US Patents:0
Tradenames:25
Ingredients:22
NDAs:24
Patent Litigation for Alvogen Malta: See patent lawsuits for Alvogen Malta

Drugs and US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 204621-002 Nov 9, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta ZESTRIL lisinopril TABLET;ORAL 019777-004 May 19, 1988 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 204737-001 Jun 26, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 207388-003 Jul 28, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-002 Jan 5, 1996 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-002 Jul 20, 1989 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 207388-005 Jul 28, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 3,663,607 ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 3,836,671 ➤ Try a Free Trial
Alvogen Malta NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-003 Jan 5, 1996 5,637,320 ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 3,934,032 ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 3,934,032 ➤ Try a Free Trial
Alvogen Malta ZESTRIL lisinopril TABLET;ORAL 019777-004 May 19, 1988 4,374,829*PED ➤ Try a Free Trial
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 3,836,671 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Chubb
Dow
Moodys
Mallinckrodt
QuintilesIMS
McKinsey
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.